Dimitar Efremov, MD, PhD, is a senior researcher at the International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Dr Efremov received his medical degree in 1986 from the University of St. Cyril and Methodius, Skopje, North Macedonia. He then went on to complete a PhD at Maastricht University, Maastricht, The Netherlands, in 1994 before returning to the University of St. Cyril and Methodius, Skopje, North Macedonia, to specialize in internal medicine and hematology. In 1993, Dr Efremov became an international research fellow at the Medical College of Georgia, Augusta, GA. From 1994 to 1998, he worked in several research positions at ICGEB, Trieste, Italy and returned to Skopje as an assistant professor in 1998. Dr Efremov then worked with ICGEB in Rome, Italy, from 2004 to 2015, before residing in Trieste, Italy, where he is positioned today.
Speaking on cellular and molecular mechanisms of CLL
Dr Efremov’s research interests are focused on the cellular and molecular mechanisms of chronic lymphocytic leukemia (CLL), in addition to the development of novel therapies. He has published over a hundred articles, several within prestigious journals such as Leukemia and Blood. He is also actively involved on the editorial boards of Haematologica, the American Journal of Blood Research, the Mediterranean Journal of Hematology and Infectious Diseases, EMJ Hematology and several other journals.